Dr Reddys Lab recalls Famotidine tablets from US market Ruby Khatun Khatun22 Oct 2017 10:17 AM ISTNew Delhi: Dr. Reddy's Laboratories has initiated voluntarily recall of over half a million Famotidine tablets bottles from the US market as the drug...
US firms approach USTR against Indias medical price control measures Ruby Khatun Khatun22 Oct 2017 9:58 AM ISTWashington: American companies producing medical devices and health information systems have approached the US Trade Representative against India's...
GlaxoSmithKline adult shingles vaccine wins US approval Ruby Khatun Khatun22 Oct 2017 9:31 AM ISTThe U.S. Food and Drug Administration approved GlaxoSmithKline's Shingrix shingles vaccine for use in adults aged 50 and over, a move widely expected...
Imprimis Pharma to take on Allergans Restasis with cheaper product Ruby Khatun Khatun22 Oct 2017 9:02 AM ISTShares of Imprimis Pharmaceuticals Inc sky-rocketed as much as 91 percent on Thursday, after the company said it would launch a cheaper alternative to...
Abbotts recent deals, medical device pipeline to fuel growth Ruby Khatun Khatun21 Oct 2017 10:11 AM ISTAbbott Laboratories quarterly results beat estimates and the company raised the top end of its full-year earnings forecast range on Wednesday, as a...
Doctor Insta to raise 4 million dollars for expansion Ruby Khatun Khatun21 Oct 2017 9:42 AM ISTAhmedabad: A video medicine platform Doctor Insta backed by RoundGlass Partners and BrahmaX Ventures is looking to raise 4 million dollars of funding...
Trump promises action on drug prices that may impact India Ruby Khatun Khatun21 Oct 2017 9:30 AM ISTWashington: US President Donald Trump has promised to bring the cost of prescription drugs way down and let other countries pay more for these...
Exelixis drug improves overall survival in liver cancer patients Ruby Khatun Khatun21 Oct 2017 9:12 AM ISTExelixis Inc's drug to treat a type of liver cancer improved overall survival in patients in a late-stage study that prompted an independent expert...
Novartis Revolade shows long-term disease control for chronic/persistent immune thrombocytopenia Ruby Khatun Khatun21 Oct 2017 9:09 AM ISTZURICH: Novartis said on Wednesday a long-term study of its Revolade drug showed good results in treating chronic and persistent immune...
Granules US partner gets ANDA approval for Prasugrel tablets Ruby Khatun Khatun20 Oct 2017 10:25 AM ISTNew Delhi: Drug firm Granules India said US pharma Windlas LLC has received approval from the US health regulator for generic Prasugrel tablets used...
Avnet, MedIoTek announces joint marketing agreement to promote VinCense system in India Ruby Khatun Khatun20 Oct 2017 9:58 AM ISTCHENNAI: Avnet, a leading global technology distributor, and MedIoTek Health Systems announced a joint marketing agreement to promote MedIoTek's...
New cancer drugs help Johnson and Johnson top profit estimates Ruby Khatun Khatun20 Oct 2017 9:35 AM ISTJohnson and Johnson posted better-than-expected third-quarter earnings, raising its full-year forecast due to growth from new cancer drugs and...
